A wound after contact between a child and a dog does not necessarily mean an animal bite.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to S O Hofer.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
For more than a century, a role for wound healing in the outgrowth of tumours has been implied based on observations in both experimental and clinical studies. Wound healing can be divided into stages of inflammatory, proliferative, repair and remodelling processes. Through proper regulation of activation of epithelial, endothelial and inflammatory cells, platelets and fibroblasts, and the production of growth factors, wounds heal and the various cell types resume their normal function. In tumour growth, similar processes of cell activation and growth factor production are observed. These processes are, however, differently regulated leading to ongoing cellular activation. In recent years, growth factors such as EGF, TGF-alpha and TGF-beta, bFGF, IGF I and II, and PDGF have been identified to play a role in the different stages of wound healing. In addition, some of these factors have now been identified as also being involved in the outgrowth of tumours. In this review, cell types involved in wound healing and tumour growth, as well as the growth factors and cytokines they produce and the role of the extracellular matrix, extensively present in both conditions, are being discussed. A better understanding of the time interval during which the sequelae of events in wound healing occur in relation to the time interval of tumour recurrence may be the basis for defining new therapeutic strategies that can interfere with tumour outgrowth without affecting wound healing processes. These new therapeutic approaches may be of importance especially after surgery or other invasive (diagnostic) procedures in cancer patients.
A modification of the technique of palmar capsulodesis described by Filler et al. (1976) for the treatment of hyperextensibility in the metacarpophalangeal joint of the thumb was used in the metacarpophalangeal joints of the fingers. Seven of eight patients regained normal range of motion without pain.
Explore the source record for details and available documents.
The thyroglossal cyst is a wellknown cause of a swelling in the neck. The generally accepted technique of treatment was described in 1928, but many recurrences are still seen in daily clinical practice. The radical technique of removal of cysts and sinuses of the thyroglossal duct according to Sistrunk is the method of choice. Over an 8-year period 40 cases were treated in this fashion in the University Hospital Groningen, the Netherlands, with an average follow-up of 5 years and 3 months; in 29 it was the first operation. Only 1 patient of the 23 treated according to Sistrunk had a recurrence for which he had to be treated again. Six patients were treated otherwise; 3 of them had a recurrence. It is concluded that the first surgery (according to Sistrunk), if correctly performed, offers the best chance for cure.
OBJECTIVE: To determine the effect of several wound factors on melanoma growth in a mouse model. DESIGN: Cohort analytic study. SETTING: Animal research facility of Roger Williams Medical Center, Providence, RI. STUDY GROUP: Seventeen groups of 5 C57BL/6 mice each. INTERVENTIONS: A surgical wound was created in 1 hind limb, after which different concentrations of B16F10 melanoma cells were injected in adjacent subcutaneous tissue. The nonwounded hind limb in the same mouse served as a control. In this fashion, a critical tumor cell dose was determined that showed tumor growth in the wounded but not the control hind limb. Tumor growth in control hind limbs then was compared with that in the "artificially wounded" hind limbs, which were co-injected with mouse wound fluid or growth factors. Early (day 1) and late (day 10) wound fluids and tumor growth factor beta (TGF-beta), basic fibroblast growth factor (bFGF), both combined, and interleukin 6 (IL-6) were used. MAIN OUTCOME MEASURE: Wound factors increase tumor growth, indicating potentiation of tumor recurrence at a surgical wound. RESULTS: The critical tumor cell dose was 10(3) cells. All growth factors and both wound fluids showed increased tumor growth over time except IL-6. Hind limbs injected with early wound fluid showed increased tumor growth over time when compared with those injected with late wound fluid (P<.001), TGF-beta (P<.001), bFGF (P<.001), and IL-6 (P<.001). Combined TGF-beta and bFGF co-injection resulted in increased tumor growth compared with TGF-beta (P<.001) and bFGF (P<.001), but did not differ significantly from early wound fluid (P<.07). CONCLUSIONS: The healing wound and its mediators in wound fluid or purified growth factors significantly enhanced tumor growth. Combining TGF-beta and bFGF increased tumor growth to a level closer to wound fluid. The inflammatory response provoked by wound healing mediators may be an important mechanism in tumor growth after ablative surgery.
Explore the source record for details and available documents.
OBJECTIVE: To determine a critical skeletal muscle oxygen tension (PO2) value below which a tissue oxygen debt develops. DESIGN: Descriptive study of oxygen transport values in relation to skeletal muscle PO2 throughout progressive ischemia by means of arterial blood flow reductions in an isolated hindlimb model in the pig. SETTING: Surgical Research department of the University of Amsterdam. SUBJECTS: Six female Yorkshire pigs weighing 26 to 35 kg (average 33). INTERVENTIONS: Controlled blood flow to the isolated hindlimb was achieved by means of extracorporeal circulation. The hindlimb was studied during progressive flow reduction. MEASUREMENTS AND MAIN RESULTS: Oxygen delivery (DO2) and oxygen consumption were calculated as the product of extracorporeal blood flow and, respectively, arterial oxygen content and arterial-venous oxygen content difference. In this fashion, an oxygen supply dependency could be determined in all animals. A critical DO2 value was determined below which a tissue oxygen debt developed. Skeletal muscle PO2 was measured continuously, using a Clark-type polarographic oxygen sensor. Combining the critical DO2 value with the corresponding skeletal muscle PO2 value resulted in a critical skeletal muscle PO2 value of 15.2 +/- 0.4 torr (2.0 +/- 0.1 kPa). CONCLUSION: In this pig model, a critical skeletal muscle PO2 value could be determined below which a tissue oxygen debt presumably developed.
A continuous intramuscular oxygen tension sensor was compared, with transcutaneous oximetry and laser Doppler flowmetry, during periods of arterial flow alterations in an isolated hindlimb model in the pig. The intramuscular oxygen tension sensor correlated well with bloodflow and was superior to the other two methods.
An intravascular oxygen tension (PO2) sensor (Continucath 1000) was used to assess flap viability in microsurgically revascularized free flaps for 36 hours postoperatively. In vitro, long term stability, linearity, and response time of the PO2 sensor proved to be excellent. In 14 patients with sound flaps tissue PO2 values were found to be between 15 and 35 mm Hg. In three cases a failing flap needed reexploration. In these cases the PO2 sensor was accurate in detecting circulatory failure while in other cases it traced a number of physiological changes. The device holds promise for free flap monitoring but further studies are indicated.
Explore the source record for details and available documents.
An overview is given of the various aspects of idiopathic proctitis. Special emphasis is given on the diagnostic possibilities especially the endoscopic appearances. The list of other inflammatory conditions to be considered in the differential diagnosis is long and includes especially infectious disorders, Crohn's disease, post-radiation abnormalities, caustic damage and ischaemic damage. The mainstay of therapy is topical application of measalazine and corticosteroids. In general measalazine appears to be equally effective as corticosteroids.
Explore the source record for details and available documents.